Stay updated on Naptumomab + Durvalumab in Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the Naptumomab + Durvalumab in Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Naptumomab + Durvalumab in Solid Tumors Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    A new site revision entry 'Revision: v3.4.2' was added to the history, and the notices for government funding lapse and the previous 'Revision: v3.4.1' were removed from deletions. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.7%
    Check dated 2026-02-11T11:30:13.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Site-wide notices about government funding and operating status were added, along with a site version update to v3.4.1 (replacing v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.7%
    Check dated 2026-02-04T07:39:51.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Introduces a Show glossary option and color-coded change legends for additions and deletions, with an updated revision badge to v3.4.0. The No FEAR Act data wording is updated between versions.
    Difference
    0.9%
    Check dated 2026-01-28T04:44:00.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    A new revision entry v3.3.4 was added to the Records History and the previous v3.3.3 entry was removed, reflecting a minor update to the page’s history. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T03:03:05.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    The footer now shows Revision: v3.3.3, and references to HHS Vulnerability Disclosure and Revision: v3.3.2 have been removed. This is a minor administrative update that does not affect the study data or page content.
    Difference
    0.2%
    Check dated 2025-12-23T12:35:50.000Z thumbnail image
  7. Check
    85 days ago
    Change Detected
    Summary
    The study status changed from Recruiting to Active, not recruiting, indicating no current enrollment. New sections for Contacts/Locations and Oversight were added to the study record.
    Difference
    0.9%
    Check dated 2025-12-01T20:30:37.000Z thumbnail image

Stay in the know with updates to Naptumomab + Durvalumab in Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Naptumomab + Durvalumab in Solid Tumors Clinical Trial page.